M&A

Dated Information Causes Human Genome To Pop
Seeking Alpha
Tue, 10/18/11 - 07:07 pm
Human Genome Sciences
GSK
M&A
Benlysta
Merck
Biogen Idec
GlaxoSmithKline to Make a Bid for Human Genome Sciences?
Yahoo/Wall St. Cheat Sheet
Tue, 10/18/11 - 12:12 pm
GSK
Human Genome Sciences
M&A
Anadys acquisition sign of more to come
The Deal
Tue, 10/18/11 - 08:53 am
Anadys
Roche
Merck
JNJ
Achillion
M&A
Indenix
Bristol-Myers Squibb
Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market
TheStreet.com
Mon, 10/17/11 - 01:22 pm
Roche
M&A
Anadys
hepatitis C
Pegasys
setrobuvir
Merck
Victrelis
RG7128
Pharmasset
Swiss pharma giant Roche to buy US-based hepatitis C specialist Anadys for $230 million
Yahoo/AP
Mon, 10/17/11 - 09:27 am
Roche
M&A
Anadys
hepatitis C
MSA Completes Sale of North Carolina Ballistic Vest Business
Fri, 10/14/11 - 05:39 pm
MSA
M&A
Carolina Ballistic Vest
M&A Looms On Med-Tech Horizon, Analyst Says
Fri, 10/14/11 - 05:25 pm
med-tech
M&A
Teva-Cephalon combination official, will have $20B in revenues
Bizjournals.com
Fri, 10/14/11 - 11:27 am
Teva Pharmaceuticals
M&A
Cephalon
Allos Therapeutics Says It Settled Lawsuits Contesting Acquisition by AMAG
Bloomberg
Fri, 10/14/11 - 11:06 am
Amag Pharmaceuticals
Allos
M&A
WuXi PharmaTech Acquires Abgent, A Leading Producer Of Biological Research Reagents
Thu, 10/13/11 - 10:38 pm
WuXi PharmaTech
M&A
Abgent
Trimeris, Synageva set date to vote on merger
Bizjournals.com
Thu, 10/13/11 - 01:24 pm
Trimeris
Synageva
M&A
OPKO Completes Sale of Ophthalmic Instrumentation Business
Wed, 10/12/11 - 08:47 pm
OPKO
ophthalmic
M&A
OPKO Completes Sale of Ophthalmic Instrumentation Business
Wed, 10/12/11 - 08:47 pm
OPKO
ophthalmic
M&A
AMAG Board Says Shareholders Should Vote for Allos Purchase
Bloomberg
Wed, 10/12/11 - 10:41 am
M&A
Allos
Amag Pharmaceuticals
NuVasive closes Impulse Monitoring deal | Acquisitions Roundup
Tue, 10/11/11 - 10:20 pm
NuVasive
Impulse Monitoring
M&A
Allos Therapeutics Falls After Counter-Offer Is Withdrawn
Bloomberg
Mon, 10/10/11 - 11:01 am
Allos
M&A
Amag Pharmaceuticals
Teva Agrees to Conditions for Drug Merger (with Cephalon)
NY Times
Sat, 10/8/11 - 11:51 am
Teva Pharmaceuticals
Cephalon
M&A
Poniard Pharmaceuticals Announces Effectiveness of Form S-4 Registration Statement for the Proposed Merger with ALLOZYNE
Yahoo/MarketWire
Sat, 10/8/11 - 11:50 am
Poniard
M&A
Allozyne
NuVasive completes $80M Impulse Monitoring deal
Sat, 10/8/11 - 11:39 am
NuVasive
Impulse Monitoring
M&A
KCI shareholders to decide fate of Apax acquisition
Thu, 10/6/11 - 10:24 pm
KCI
Apax
M&A

Pages